Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer

Little is known regarding the effectiveness and tolerability of immune checkpoint inhibitor (ICI) rechallenge after disease progression following initial ICI treatments. To identify eligible patients for ICI rechallenge, we retrospectively analyzed the relationship between clinical profiles and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Yuki, Shimamoto, Takayuki, Yamada, Tadaaki, Takeda, Takayuki, Yamada, Takahiro, Shiotsu, Shinsuke, Chihara, Yusuke, Hiranuma, Osamu, Iwasaku, Masahiro, Kaneko, Yoshiko, Uchino, Junji, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019787/
https://www.ncbi.nlm.nih.gov/pubmed/31906082
http://dx.doi.org/10.3390/jcm9010102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019787/
https://www.ncbi.nlm.nih.gov/pubmed/31906082
http://dx.doi.org/10.3390/jcm9010102

Ejemplares similares